SWHR Provides Comments to CMS on NCA on Beta Amyloid PET in Dementia and Neurodegenerative Disease


Published 7/19/22

SWHR provided comments to the Centers for Medicare and Medicaid Services (CMS) on its reconsideration of the National Coverage Determination for Beta Amyloid Positron Emission Tomography (PET) in Dementia and Neurodegenerative Disease. In its comments, SWHR expressed support for the reconsideration as well as the removal of CMS’ current one PET scan per patient per lifetime coverage policy.

Read The Comments